Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 10/2004

01-10-2004 | Original Paper

Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins

Authors: Jie-Feng Cui, Yin-Kun Liu, Bo-Shen Pan, Hai-Yan Song, Yu Zhang, Rui-Xia Sun, Jie Chen, Ju-Tao Feng, Zhao-You Tang, Yan-Ling Yu, Hua-Li Shen, Peng-Yuan Yang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2004

Login to get access

Abstract

Purpose

The comparative study of differentially expression of protein profiles of hepatocellular carcinoma cell lines with various metastasic potential and screening key molecules related to hepatocellular carcinoma metastasis and recurrence.

Methods

Using two-dimensional electrophoresis and liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), we analyzed differentially displayed proteomics of human hepatocellular carcinoma cell lines Hep3B, MHCC97L, MHCC97H with different metastasic potential.

Results

Approximate 1,000 protein spots were detected on silver-stained gel by ImageMaster (977±113 spots in Hep3B, 1092±40 in MHCC97L, and 889±14 in MHCC97H). Fifty distinct different protein spots were analyzed with online LC-ESI-MS/MS. Only 26 protein spots had a positive result, including annexin1, S100A4, and so on. In comparison with nonmetastasis Hep3B cell lines, there were 16 proteins overexpressed in MHCC97H and MHCC97L, 10 proteins underexpressed in MHCC97H and MHCC97L. Applying cell immunohistochemistry and RT-PCR, we further validated two interesting and different proteins, annexin1 and S100A4.

Conclusion

The protein profile of metastatic hepatocellular carcinoma cell lines displayed obvious differences compared with non-metastatic liver cancer cell lines. The results imply that various different proteins may lead to HCC metastasis together.
Literature
go back to reference Brunagel G, Schoen RE, Bauer AJ, Vietmeier BN, Getzenberg RH (2002) Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res 8:3039–3045PubMed Brunagel G, Schoen RE, Bauer AJ, Vietmeier BN, Getzenberg RH (2002) Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin Cancer Res 8:3039–3045PubMed
go back to reference Coffey DS(2002) Nuclear matrix proteins as proteomic marks of preneoplastic and cancer lesions. Clin Cancer Res 8:3031–3033PubMed Coffey DS(2002) Nuclear matrix proteins as proteomic marks of preneoplastic and cancer lesions. Clin Cancer Res 8:3031–3033PubMed
go back to reference Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J (2000) Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191:381–388CrossRefPubMed Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J (2000) Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191:381–388CrossRefPubMed
go back to reference Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J, Akedo H, Tatsuta M, Nakamura H (2000) Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer 83:769–774CrossRefPubMed Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J, Akedo H, Tatsuta M, Nakamura H (2000) Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer 83:769–774CrossRefPubMed
go back to reference Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630–636PubMed Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7:630–636PubMed
go back to reference Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, Maeba T, Sogawa K, Konishi R, Taniguchi K, Hatanaka Y, Hatase O, Nishioka M (1996) Enhanced expression of protein kinase substrate annexin1 in human hepatocellular carcinoma. Hepatology 24:72–81CrossRefPubMed Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, Maeba T, Sogawa K, Konishi R, Taniguchi K, Hatanaka Y, Hatase O, Nishioka M (1996) Enhanced expression of protein kinase substrate annexin1 in human hepatocellular carcinoma. Hepatology 24:72–81CrossRefPubMed
go back to reference Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y, Kuroda Y (2002) Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20:937–941PubMed Nakamura T, Ajiki T, Murao S, Kamigaki T, Maeda S, Ku Y, Kuroda Y (2002) Prognostic significance of S100A4 expression in gallbladder cancer. Int J Oncol 20:937–941PubMed
go back to reference Pedersen KB, Nesland JM, Fodstad, Malandsmo GM (2002) Expression of S100A4, E-Cadherin, α- and β-catenin in breast cancer biopsies. Br J Cancer 87:1281–1286CrossRefPubMed Pedersen KB, Nesland JM, Fodstad, Malandsmo GM (2002) Expression of S100A4, E-Cadherin, α- and β-catenin in breast cancer biopsies. Br J Cancer 87:1281–1286CrossRefPubMed
go back to reference Soskic V, Gorlach M, Poznanovic S, Boehmer FD, Godovac-Zimmermann J (1999) Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor βreceptor. Biochemistry 38:1757–1764CrossRefPubMed Soskic V, Gorlach M, Poznanovic S, Boehmer FD, Godovac-Zimmermann J (1999) Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor βreceptor. Biochemistry 38:1757–1764CrossRefPubMed
go back to reference Steiner S, Witzmann FA (2000) Proteomics: application and opportunities in preclinical drug development. Electrophoresis 21:2099–2104CrossRefPubMed Steiner S, Witzmann FA (2000) Proteomics: application and opportunities in preclinical drug development. Electrophoresis 21:2099–2104CrossRefPubMed
go back to reference Tang ZY(2000) Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today 4:191–195 Tang ZY(2000) Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today 4:191–195
go back to reference Tang ZY(2003). Overview. In: Tang ZY (ed) Metastasis and recurrence of hepatocellular carcinoma basic and clinical studies. Shanghai Science and Technology, Shanghai, pp 1–24 Tang ZY(2003). Overview. In: Tang ZY (ed) Metastasis and recurrence of hepatocellular carcinoma basic and clinical studies. Shanghai Science and Technology, Shanghai, pp 1–24
go back to reference Tang ZY, Yu YQ, Zhou XD, Ma ZC, Wu ZQ (1998) Progress and prospects in hepatocellular carcinoma surgery. Ann Chir 52:558–563PubMed Tang ZY, Yu YQ, Zhou XD, Ma ZC, Wu ZQ (1998) Progress and prospects in hepatocellular carcinoma surgery. Ann Chir 52:558–563PubMed
go back to reference Tang ZY, Zhou XD, Li ZY, Yang BH, Ma ZC, Ye SL, Wu ZQ, Fan J, Liu YK, Liu KD, Qin LX, Tian J, Sun HC, He B, Xia JL, Qiu SJ, Zhou J (1999) Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin Med J 112:887–891PubMed Tang ZY, Zhou XD, Li ZY, Yang BH, Ma ZC, Ye SL, Wu ZQ, Fan J, Liu YK, Liu KD, Qin LX, Tian J, Sun HC, He B, Xia JL, Qiu SJ, Zhou J (1999) Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Chin Med J 112:887–891PubMed
go back to reference Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81:814–821CrossRefPubMed Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81:814–821CrossRefPubMed
go back to reference Timperman AT, Aebersold R (2000) Peptide electroextraction for direct coupling of in gel digests with capillary LC-MS/MS for protein identification and sequencing. Anal Chem 72:4115–4121CrossRefPubMed Timperman AT, Aebersold R (2000) Peptide electroextraction for direct coupling of in gel digests with capillary LC-MS/MS for protein identification and sequencing. Anal Chem 72:4115–4121CrossRefPubMed
go back to reference Wu WG, Tang XM, Hu W, Lotan R, Hong EK, Mao L (2002) Identification and validation of metastasis-associated protein in head and neck cancer cell line by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19:319–326CrossRefPubMed Wu WG, Tang XM, Hu W, Lotan R, Hong EK, Mao L (2002) Identification and validation of metastasis-associated protein in head and neck cancer cell line by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19:319–326CrossRefPubMed
go back to reference Yu LR, Zeng R, Shao XX, Wang N, Xu YH, Xia QC (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21:3058–3068CrossRefPubMed Yu LR, Zeng R, Shao XX, Wang N, Xu YH, Xia QC (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21:3058–3068CrossRefPubMed
go back to reference Zeindl-Eberhart E, Klugbauer S, Dimitrijevic N, Jungblut PR, Lamer S, Rabes HM (2001) Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Electrophoresis 22:3009–3018CrossRefPubMed Zeindl-Eberhart E, Klugbauer S, Dimitrijevic N, Jungblut PR, Lamer S, Rabes HM (2001) Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Electrophoresis 22:3009–3018CrossRefPubMed
Metadata
Title
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins
Authors
Jie-Feng Cui
Yin-Kun Liu
Bo-Shen Pan
Hai-Yan Song
Yu Zhang
Rui-Xia Sun
Jie Chen
Ju-Tao Feng
Zhao-You Tang
Yan-Ling Yu
Hua-Li Shen
Peng-Yuan Yang
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 10/2004
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-004-0576-5

Other articles of this Issue 10/2004

Journal of Cancer Research and Clinical Oncology 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.